Nom du produit:2-fluoro-1-(isocyanatomethyl)-4-(trifluoromethoxy)benzene
IUPAC Name:2-fluoro-1-(isocyanatomethyl)-4-(trifluoromethoxy)benzene
- CAS：2837996-40-2
- Formule moléculaire：C9H5F4NO2
- Pureté：95%+
- Numéro de catalogue：CM1046376
- Poids moléculaire：235.14
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2837996-40-2
- Formule moléculaire:C9H5F4NO2
- Point de fusion:-
- Code SMILES:FC1=C(CN=C=O)C=CC(OC(F)(F)F)=C1
- Densité:
- Numéro de catalogue:CM1046376
- Poids moléculaire:235.14
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- JNT-517
- Jnana Therapeutics announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all ages and genotypes. Based on these positive mid-term results, Jnana has adjusted its phase 1b clinical trial design to support the critical phase 3 clinical trial of JNT-517 starting in the first half of 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
